51 related articles for article (PubMed ID: 20123450)
1. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.
Jones C; Damiani S; Wells D; Chaggar R; Lakhani SR; Eusebi V
Am J Pathol; 2001 Jan; 158(1):207-14. PubMed ID: 11141494
[TBL] [Abstract][Full Text] [Related]
3. All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.
Shousha S; Anscombe O; McFarlane T
Pathol Oncol Res; 2020 Apr; 26(2):1073-1078. PubMed ID: 31044387
[TBL] [Abstract][Full Text] [Related]
4. Apocrine and clear cell metaplasia in the gallbladder: the first finding in the medical literature.
Al-Janabi MH
Oxf Med Case Reports; 2024 May; 2024(5):omae052. PubMed ID: 38784780
[TBL] [Abstract][Full Text] [Related]
5. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
[TBL] [Abstract][Full Text] [Related]
6. Apocrine secretion in Drosophila salivary glands: subcellular origin, dynamics, and identification of secretory proteins.
Farkaš R; Ďatková Z; Mentelová L; Löw P; Beňová-Liszeková D; Beňo M; Sass M; Řehulka P; Řehulková H; Raška O; Kováčik L; Šmigová J; Raška I; Mechler BM
PLoS One; 2014; 9(4):e94383. PubMed ID: 24732043
[TBL] [Abstract][Full Text] [Related]
7. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
Asirvatham JR; Falcone MM; Kleer CG
Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
[TBL] [Abstract][Full Text] [Related]
8. Non-operative breast pathology: apocrine lesions.
Wells CA; El-Ayat GA
J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Histopathology; 2009 Feb; 54(3):348-54. PubMed ID: 19236511
[TBL] [Abstract][Full Text] [Related]
11. Cell turnover in apocrine metaplasia of the human mammary gland epithelium: apoptosis, proliferation, and immunohistochemical detection of Bcl-2, Bax, EGFR, and c-erbB2 gene products.
Feuerhake F; Unterberger P; Höfter EA
Acta Histochem; 2001 Feb; 103(1):53-65. PubMed ID: 11252628
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the cell cycle regulators cyclin D1, cyclin A, p27, p21, p16, and pRb in apocrine metaplasia of the breast.
Elayat G; Selim AG; Wells CA
Breast J; 2009; 15(5):475-82. PubMed ID: 19624419
[TBL] [Abstract][Full Text] [Related]
13. C-myc oncoprotein expression and gene amplification in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Naase M; Wells CA
Breast; 2002 Dec; 11(6):466-72. PubMed ID: 14965711
[TBL] [Abstract][Full Text] [Related]
14. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
